InvestorsHub Logo
Followers 15
Posts 1231
Boards Moderated 0
Alias Born 12/16/2020

Re: None

Wednesday, 12/14/2022 1:53:42 PM

Wednesday, December 14, 2022 1:53:42 PM

Post# of 426714
We need Abbvie to buy us..... they have big stones to go along with brains.

Under US patent law, it is possible to file for what is known as a “continuation” on an existing patent, to cover even slight modifications of the original formula, of the potency, or new applications. This creates families of patents built around a core feature, which end up adding years to the original patent timeline.

Sounds like a perfect fit for the new formula.

https://finance.yahoo.com/news/abbvie-denied-americans-access-fair-164600995.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News